32 phenotypes from 3 alleles in 7 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Npc2Gt(LST105)Byg/Npc2Gt(LST105)Byg B6.129P2-Npc2Gt(LST105)Byg	abnormal immune system morphology	J:125609
	abnormal immune system physiology	J:125609
Npc2tm1e.1(EUCOMM)Wtsi/Npc2+ C57BL/6N-Npc2tm1e.1(EUCOMM)Wtsi/Tcp	increased circulating potassium level	J:211773
	small adrenal glands	J:211773
Npc2tm1Plob/Npc2tm1Plob C.129S1-Npc2tm1Plob	abnormal lysosome morphology	J:125609
	abnormal NK cell physiology	J:125609
	abnormal T cell physiology	J:125609
	decreased NK cell number	J:125609
Npc2tm1Plob/Npc2tm1Plob involves: 129S1/Sv	premature death	J:89617
Npc2tm1Plob/Npc2tm1Plob involves: 129S1/Sv * BALB/c	abnormal alveolar macrophage morphology	J:204311
	abnormal lipid level	J:204311
	abnormal lung morphology	J:204311
	abnormal lung vasculature morphology	J:204311
	abnormal phospholipid level	J:204311
	abnormal surfactant composition	J:204311
	abnormal type II pneumocyte morphology	J:204311
	decreased body weight	J:204311
	increased alveolar lamellar body number	J:204311
	increased cholesterol level	J:204311
	increased lung weight	J:204311
	lipidosis	J:204311
	pulmonary alveolar proteinosis	J:204311
	small alveolar lamellar bodies	J:204311
	thick pulmonary interalveolar septum	J:204311
Npc2tm1Plob/Npc2tm1Plob involves: 129S1/Sv * BALB/c * C57BL/6	abnormal lipid homeostasis	J:89617
	abnormal locomotor behavior	J:89617
	ataxia	J:89617
	decreased Purkinje cell number	J:89617
	increased liver cholesterol level	J:89617
	premature death	J:89617
	Purkinje cell degeneration	J:89617
	tremors	J:89617
	weight loss	J:89617
Npc2tm1Plob/Npc2tm1Plob involves: 129S1/Sv * C57BL/6	decreased NK cell number	J:125609
	premature death	J:89617